Non-vitamin K antagonist oral anticoagulation agents in patients with atrial fibrillation: Insights from Italian monitoring registries

BACKGROUND: Atrial fibrillation (AF) is the most common cardiac arrhythmia associated with an increased risk of stroke and thromboembolism. Anticoagulation with Vitamin K antagonists (VKAs) or with novel oral anti-coagulants (NOACs) represents the cornerstone of the pharmacological treatment to redu...

Descripción completa

Detalles Bibliográficos
Autores principales: Olimpieri, P.P., Di Lenarda, A., Mammarella, F., Gozzo, L., Cirilli, A., Cuomo, M., Gulizia, M.M., Colivicchi, F., Murri, G., Gabrielli, D., Trotta, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994529/
https://www.ncbi.nlm.nih.gov/pubmed/32021902
http://dx.doi.org/10.1016/j.ijcha.2019.100465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994529/
https://www.ncbi.nlm.nih.gov/pubmed/32021902
http://dx.doi.org/10.1016/j.ijcha.2019.100465

Ejemplares similares